Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fineqia Launches World’s First ETN Deploying Underlying Assets in DeFi (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kneat.com Inc KSIOF


Primary Symbol: T.KSI

Technology Software - Application
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:KSI)

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

GlobeNewswire January 9, 2025

Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation

GlobeNewswire December 17, 2024

ALTEN Selects Kneat to Digitize Validation

GlobeNewswire November 27, 2024

Kneat Achieves Record Results in Growth and Profitability

GlobeNewswire November 6, 2024

Global Medical Devices Manufacturer Selects Kneat to Digitize Validation

GlobeNewswire October 31, 2024

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024

GlobeNewswire October 30, 2024

Kneat Announces Closing of $35.6 Million Bought Deal

GlobeNewswire October 10, 2024

Global Pharma Selects Kneat to Digitize Computer System Validation

GlobeNewswire October 8, 2024

Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

GlobeNewswire October 7, 2024
View More News ››

Opinion & Analysis (TSX:KSI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:KSI)

From substack

From ceo.ca https://capitallight.substack.com/p/kneat-a-capital-light-smallcap-saas
Possibleidiot01 - 9 hours ago

Linkedin - partner announcement

Don't remember seeing this. Malek E.Malek E. • 3rd+ • 3rd+ Talent Acquisition Partner | Headhunter @Capgemini Engineering...
Possibleidiot01 - 5 days ago

Positive NR

Clearly the market likes this news. Up over 4% on a very tough day and just past the halfway point, it's already one of  the top...
retiredcf - January 10, 2025

Podcast

09 Monthly Rollup: Small-cap stocks; Rockets & Duds https://www.youtube.com/watch?v=GKsAWgridNc KSI is the first stock featured...
retiredcf - December 29, 2024

Recommendation

KSI is a small company ($552M market cap) and while it is currently unprofitable, it is expecting strong growth rates in the next few...
retiredcf - December 21, 2024

fund manager Martin Mathieu comment

November was extremely busy with third-quarter results. There were too many to highlight in detail here, but I encourage you to...
Possibleidiot01 - December 5, 2024
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a pharmaceutical company. The Company is engaged in developing a platform for biologically guided ...
View More »